Bristol-Myers Squibb (BMY) Tops Q4 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Go back to Bristol-Myers Squibb (BMY) Tops Q4 EPS by 1c

Bristol-Myers Squibb Co. (BMY) PT Raised to $74 at BMO Capital

February 7, 2022 7:21 AM EST

BMO Capital analyst Evan David Seigerman raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $74.00 (from $72.00) while maintaining an Outperform rating.

The analyst commented, "Concerns around Revlimids erosion still overshadow the growth from the new product portfolio, but the... More